¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"rebound relapse"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
¿µ¹® rebound phenomenon ÇÑ±Û ¹Ý¹ßÇö»ó, ¹Ýµ¿Çö»ó
¼³¸í   
  ¼Ò³ú ±â´ÉÀå¾Ö¿¡¼­ »çÁöÀÇ ´ëÇ×±ÙÀ° »çÀÌÀÇ ÇùÁ¶¼º »ó½ÇÀǠ¡Èķμ­, È¯ÀÚ¿¡°Ô ¾çÆÈÀ» ¼öÆòÀ¸·Î »¸°Ô ÇÏ°í ±× ÆÈÀ» °­ÇϰԠġ¸é Á¤»óÀΠ°æ¿ì´Â °ð ¿ø»óÀ¸·Î ¿Ã¸®´Âµ¥ ºñÇÏ¿© È¯ÀÚ¿¡ À־´Â ¿øÀ§Ä¡·Î µ¹¾Æ¿À´Â µ¥ ¸î ¹øÀ̳ª ¶³°Ô µÈ´Ù.
¿µ¹® recurrence, relapse ÇÑ±Û Àç¹ß
¼³¸í   
  º´¿øÃ¼ µîÀÇ °¨¿°À¸·Î »ý±â ¿°Áõ¼ºÁúȯÀÌ Çѹø Ä¡À¯µÈ ÈÄ¿¡ ´Ù½Ã µ¿ÀÏÇÑ º´¿øÃ¼ÀÇ °¨¿°À¸·Î ¶Ç´Ù½Ã Áúº´À» ÀÏÀ¸Å² °æ¿ì¿Í ¼ö¼úÀ̳ª ¹æ»ç¼±Á¶»ç·Î Ä¡·á ÈÄ¿¡ µ¿ÀÏÇüÀÇ Á¾¾çÀÌ ´Ù½Ã °°Àº ºÎÀ§¿¡ ¹ßÇöµÇ´Â °æ¿ìÀÌ´Ù. ÈÄÀÚÀÇ °æ¿ì Àç¹ßÀÇ ¼º¸³¿¡´Â ¨ç ¶¼´Ù ³²Àº Á¾¾ç¼¼Æ÷°¡ Áõ½ÄÇϴ Á÷Á¢°³¹ß(±¹¼Ò¼ºÀç¹ß°ú ÀüÀ̼ºÀç¹ß)°ú ¨è Á¾¾ç¼¼Æ÷°¡ ¿ÏÀüÈ÷ Á¦°ÅµÈ ÈÄ¿¡ »õ·Ó°Ô °°Àº Á¾·ùÀÇ Á¾¾çÀÌ ¹ß»ýÇϴ °£Á¢Àç¹ßÀÌ ÀÖ´Ù. Àç¹ßÀ̶ó´Â Çö»óÀº ÀϹÝÀûÀ¸·Î ¾Ç¼ºÁ¾¾ç¿¡¼­ ¸¹Áö¸¸ µå¹°°Ô ¾ç¼ºÁ¾¾ç¿¡¼­µµ ±¹¼Ò¼ºÀç¹ßÇüÀÌ ³ªÅ¸³ª´Â °æ¿ì°¡ ÀÖ´Ù. 
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • late relapse
    ¸¸±âÀç¹ß, ´ÊÀºÀç¹ß
  • relapse
    Àç¹ß
  • rebound
    1. ¹Ýµ¿- 2. ¹Ýµ¿
  • rebound hyperglycemia
    ¹Ýµ¿°íÇ÷´ç(Áõ)
  • rebound nystagmus
    ¹Ýµ¿´«¶³¸², ¹Ýµ¿¾ÈÁø
  • rebound phenomenon
    ¹Ýµ¿Çö»ó
  • rebound tenderness
    ¹Ýµ¿¾ÐÅë, µÇƦÅëÁõ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • relapse
    Àç¹ß
  • rebound phenomenon
    ¹Ýµ¿Çö»ó
  • rebound
    ¹Ýµ¿, ¹Ýµ¿-
  • rebound tenderness
    ¹Ýµ¿¾ÐÅë, µÇƦÅëÁõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • late relapse
    ¸¸±âÀç¹ß, ´ÊÀºÀç¹ß
  • relapse
    Àç¹ß
  • rebound hyperglycemia
    ¹Ýµ¿°íÇ÷´çÁõ
  • rebound hypertension
    ¹Ýµ¿°íÇ÷¾Ð
  • rebound nystagmus
    ¹Ýµ¿´«¶³¸²
  • rebound phenomenon
    ¹Ý¹ßÇö»ó, ¹Ýµ¿Çö»ó
  • rebound
    ¹Ýµ¿¼º, ¹Ý¹ß, ¹Ýµ¿
  • rebound tenderness
    ¹Ýµ¿¾ÐÅë, µÇƦÅëÁõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • indirect tenderness =rebound t.
    °£Á¢¾Ð Åë(¡­äâ÷Ô).
  • indirect tenderness =rebound t.
    °£Á¢¾ÐÅë(¡­¾ÐÅë).
  • free from relapse
    ¹«Àç¹ß
  • relapse
    Àç¹ß(î¢Û¡).
  • relapse
    Àç¹ß
  • relapse caries ³ª c. recidivus
    Àç¹ß¿ì½Ä(î¢Û¡ó»ãÚ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • free from relapse
    ¹«Àç¹ß
  • late relapse
    ¸¸±âÀç¹ß.
  • relapse
    Àç¹ß
  • relapse
    Àç¹ß(î¢Û¡).
  • relapse caries ³ª c. recidivus
    Àç¹ß¿ì½Ä(î¢Û¡ó»ãÚ).
  • indirect tenderness =rebound t.
    °£Á¢¾ÐÅë(¡­¾ÐÅë).
  • indirect tenderness =rebound t.
    °£Á¢¾Ð Åë(¡­äâ÷Ô).
  • rebound
    ¹Ýµ¿(ÚãÔÑ)
  • rebound hyperglycemia
    ¹Ýµ¿°íÇ÷´ç.
  • rebound hypertension
    ¹Ýµ¿¼º °íÇ÷¾Ð.
  • rebound nystagmus
    ¹Ýµ¿¾ÈÁø
  • rebound tenderness
    ¹Ýµ¿¾ÐÅë.
  • steroid rebound phenomenon
    ½ºÅ×·ÎÀÌµå ¹ÝµµÇö»ó(¡­ÚãÔ¯úÞßÚ).
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • relapse
    Àç¹ß
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • relapse
    Àç¹ß
  • rebound
    ¹Ýµ¿¼º, ¹Ýµ¿Çö»ó
  • rebound phenomenon
    ¹Ýµ¿Çö»ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MRT magnetic resonance tomography; maximum relaxation time; median range score; median reaction time; me...
RFS relapse-free survival; renal function study; rotating frame spectroscopy
RT Rebound Tenderness
T/RT Tenderness/Rebound Tenderness
PIR postinhibition rebound; protein identification resource
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PIR Postinhibitory rebound
FFR Freedom from relapse
R.F.S. Relapse Free Survival
RP Relapse Prevention
RFS Relapse free
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • relapse caries
    Àç¹ß ¿ì½Ä
  • rebound
    ¹Ýµ¿¼º
    ÀÚ±ØÀÇ Á¦°Å ½Ã¿¡ º¼¼ö ÀÖ´Â ¿ª¹æÇâÀÇ ¹ÝÀÀ.
  • rebound phenomenon
    ¹Ýµ¿ Çö»ó
    ¼Ò³ú ±â´É Àå¾Ö¿¡¼­ »çÁöÀÇ ±æÇ×±Ù »çÀÌÀÇ ÇùÁ¶¼º »ó½ÇÀÇ Â¡Èķμ­, ȯÀÚ¿¡°Ô ¾çÆÈÀ» ¼öÆòÀ¸·Î »¸°Ô ÇÏ°í ±× ÆÈÀ» °­ÇÏ°Ô Ä¡¸é Á¤»óÀÎ °æ¿ì´Â °ð ¿ø»óÀ¸·Î ¿Ã¸®´Â µ¥ ºñÇÏ¿© ȯÀÚ¿¡ À־´Â ¿øÀ§Ä¡·Î µ¹¾Æ¿À´Â µ¥ ¸î ¹øÀ̳ª ¶³°Ô µÈ´Ù.
  • rebound tenderness
    ¹Ýµ¿¼º ¾ÐÅë, ¹Ýµ¿ ¾ÐÅë
    ´©¸£´Â ÈûÀ» Á¦°ÅÇÒ ¶§¿¡ ´À³¢´Â µ¿Åë.
  • steroid rebound phenomenon
    ½ºÅ×·ÎÀÌµå ¹Ýµµ Çö»ó
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
relapse The return of symptoms and signs of a disease after a period of improvement.
(12 May 1997)
testicular relapse <oncology> Recurrence of leukaemia in the testicles. The disease may be restricted to the testicles or may also show evidence of disease in either the bone marrow or CNS. Treatment will depend on the timing and extent of relapsed disease.
(13 Jan 1998)
rebound Just like a rebound in basketball when the ball reverses its course and bounces back off the backboard, in medicine a rebound is a reversal of response upon withdrawal of the stimulus.
(12 Dec 1998)
rebound effect The characteristic of a drug to produce reverse effects when either the effect of the drug has passed or when the patient no longer responds to the drug.
(18 Nov 1997)
rebound phenomenon Generally, any phenomenon in which a variable that has been displaced from its normal state by a disturbing influence temporarily deviates from normal in the opposite direction when the disturbing influence is suddenly removed, before finally stabilizing at its normal state, i.e., a phenomenon involving undershoot; e.g., the subsequent hypoglycaemia that may follow injection of glucose, because the initial hyperglycaemia caused excessive secretion of insulin.
Synonym: Stewart-Holmes sign
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • relapse
    Àç¹ß
  • relapse
    (¿ø·¡ÀÇ ³ª»Û »óÅ¿¡)µÇµ¹¾Æ°¡´Ù;´Ù½Ã ³ª»Û±æ¿¡ ºüÁö´Ù;Ÿ¶ô(Åðº¸)ÇÏ´Ù;(»ç¶÷ÀÌ)º´ÀÌ µµÁö´Ù(Àç¹ßÇÏ´Ù);(¿ø·¡ÀÇ ³ª»Û »óÅ·Î)µÇµ¹¾Æ°¨;Ÿ¶ô;Åðº¸;(º´ÀÇ)Àç¹ß;µµÁü;relapser
  • rebound
    µÇÆ¢´Ù
  • rebound
    (°ø µîÀÌ)µÇ Æ¢´Ù;(ÇàÀ§°¡)(Àڱ⿡°Ô·Î)µÇµ¹¾Æ¿À´Ù;(ÁÂÀý.½ÇÆÐ µî¿¡¼­)´Ù½Ã ÀϾ´Ù;¹ÝÇâÇÏ´Ù;µÇÆ¢°ÔÇÏ´Ù;µ¹ÀÌŰ´Ù;¹ÝÇâ½ÃŰ´Ù;µÇƦ;¹ÝÇâ;¹Ý¹ß;»ê¿ï¸²(echo);¹Ýµ¿(°¨Á¤µîÀÇ);¸®¹Ù¿îµå(º¼)
  • rebound
    REBINDÀÇ °ú°Å.°ú°ÅºÐ»ç
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á